Inogen Inc INGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $6.77
- Day Range
- $5.05–6.35
- 52-Week Range
- $5.05–7.67
- Bid/Ask
- $5.50 / $6.11
- Shares Outstanding
- 26.54M
- Market Cap
- $160.03M
- Volume/Avg
- 975,015 / 315,639
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.52
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 7.03%
Company Profile
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 753
- Website
- https://www.inogen.com
Valuation
Metric | INGN |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.02 |
Price/Sales | 0.52 |
Price/Cash Flow | 40.99 |
Price/Earnings
INGN
Financial Strength
Metric | INGN |
|---|---|
Quick Ratio | 2.14 |
Current Ratio | 2.74 |
Interest Coverage | — |
Quick Ratio
INGN
Profitability
Metric | INGN |
|---|---|
Return on Assets (Normalized) | −2.85% |
Return on Equity (Normalized) | −4.48% |
Return on Invested Capital (Normalized) | −5.97% |
Return on Assets
INGN
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|q@mv@Pr | LOCK|hPMf | $190B | |||
| Medtronic PLC MDT | LOCK|x$^!q% | LOCK|!?rG> | $130B | |||
| Stryker Corp SYK | LOCK|tHFhc%! | LOCK|MkB | $124B | |||
| Boston Scientific Corp BSX | LOCK|R<C!bhN | LOCK|#><C | $62B | |||
| Edwards Lifesciences Corp EW | LOCK|kyZX%HYy | LOCK|>GTJ | $59B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|<#!tkF | LOCK|y>l | $37B | |||
| Koninklijke Philips NV ADR PHG | LOCK|&F | LOCK|#< | $30B | |||
| DexCom Inc DXCM | LOCK|hQzcHH! | LOCK|Zt#?F | $30B | |||
| Steris PLC STE | LOCK|hnm#<< | LOCK|dD#&h | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|^$VjV?l | LOCK|Rx | $20B |
United States